RE: £16 ???12 Nov 2021 09:52
Not me.
ALL THE HYPE about splitting the company in two which will mean 1. two bod of directors extra costs. 2. ALL that has happened in the last 6 months is that money has been moved around in the company. so that new GSK HAS NO DEBT and the consumer side is loaded with debt. 3. The div will have been cut expansion new drugs will be created by buying up smaller companies. I will sell at 1600- 1620 and stay away.